Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis
- Authors: Panafidina TA1, Popkova GV1, Alekberova ZS1, Mach ÉS1, Aleksandrova EN1, Nasonov EL1
-
Affiliations:
- ГУ Институт ревматологии РАМН, Москва
- Issue: Vol 80, No 5 (2008)
- Pages: 41-46
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30167
- ID: 30167
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T A Panafidina
ГУ Институт ревматологии РАМН, Москва
G V Popkova
ГУ Институт ревматологии РАМН, Москва
Z S Alekberova
ГУ Институт ревматологии РАМН, Москва
É S Mach
ГУ Институт ревматологии РАМН, Москва
E N Aleksandrova
ГУ Институт ревматологии РАМН, Москва
E L Nasonov
ГУ Институт ревматологии РАМН, Москва
References
- Насонова В. А. Системная красная волчанка. М.: Медицина; 1972.
- Abu-Shakra М., Urowitz М. В., Gladman D. D. el al. Mortality studies in systemic lupus erythematosus: results from a single center. I. Causes of death. J. Rheumatol. 1995; 22: 1259-1264.
- Насонов E. Л. Антифосфолипидный синдром. M.: Литтерра; 2004.
- Urowitz М. В., Bookman А. А. M., Koehler В. Е. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 1976; 60: 221-225.
- Badui E., Garcia-Rubi D., Robles E. et al. Cardiovascular manifestations in systemic lupus erythematosus: prospective study in 100 patients. Angiology 1985; 36: 431-441.
- Gladman D. D., Urowitz M. B. et al. Morbidity in systemic lupus erythematosus. J. Rheumatol. 1987; 14: 223-226.
- Jonsson H., Nived O., Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from defined population. Medicine (Baltimore) 1989; 68: 141-150.
- Petri M., Perez-Gutthann S., Spence D., Hochberg M. С. Risk factor for coronary arthery disease in patients with systemic lupus erythematosus. Am. J. Med. 1992; 93: 513-519.
- Heart-Holmes M., Baethege B. A., Broadwell L., Wolf R. E. Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus. J. Rheumatol. 1995; 22: 450-454.
- Stahl-Hallengren C., Jonsen A., Nived O. et al. Incidence studies of systemic lupus erythematosus in southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J. Rheumatol. 2000; 27: 685-691.
- Manzi S., Meilahn E. N., Rairie J. E. et al. Age specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am. J. Epidemiol. 1997; 145: 408-415.
- Asanuma Y., Oeser A., Shintani A. K. et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 2003; 349: 2407-2415.
- Bruce I. N., Burns R. J., Gladman D. D., Urowitz M. B. A study of myocardial perfusion abnormalities in women with systemic lupus erythematosus. J. Rheumatol. 1998; 25: 72.
- Detrano R. C., Wong N. D., Doherty Т. M. et al. Coronary calcium docs not accurately predict near-term future coronary events in high-risk adults. Circulation 1999; 25: 2633-2638.
- Doberty N. E., Seigel R. J. Cardiovascular manifestations of systemic lupus erythematosus. Am. Heart J. 1985; 110: 1257-1265.
- Fukumoto S., Tsumagari Т., Kinjo M., Tanaka K. Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy. Acta Pathol. Jpn 1987; 37: 1-9.
- Hosenpud J. D., Montanaro A., Hart M. V. Myocardial perfusion abnormalities in asymptomic patients with systemic lupus erythematosus. Am. J. Med. 1984; 77: 286-292.
- Sella E. M., Sato E. I., Barbieri A. Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy. Arthr. and Rheum. 2003; 48: 3168-3175.
- Solberg L. A., Strong J. P. Risk factors and atherosclerotic lesions. A review of autopsy studies. Atherosclerosis 1983; 3: 187-198.
- Okamaura H., Tsutsi H., Komatsu T. et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88-91.
- Dinarello C. A. Interleukin-1. Cytokine Growth Factor Rev. 1997; 8: 253-265.
- Micallef M. J., Ohtsuki Т., Kohno K. et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 1996; 26: 1647-1651.
- Tsutsui H., Nakanishi K., Matsui K. et al. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 1996; 157: 3967-3973.
- Xu D., Chan W. L., Leung B. P. et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 1998; 188: 1485-1492.
- Gerdes N., Sukhova G. K., Libby P. et al. Expression of interleukin (IL) - 18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells and macrophages: implications for atherogenesis. J. Exp. Med. 2002; 195: 245-257.
- Nakanishi K., Yoshimoto T., Tsutsui H. et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 2001; 19: 423-474.
- Puren A. J., Fantuzzi G., Gu Y. et al. Interleukin - 18 (IFN-γ-inducing factor) induces IL-8 and IL-1Β via TNFα production from non CD 14+ human blood mononuclear cells. J. Clin. Invest. 1998; 101: 711-721.
- Mallat Z., Corbaz A., Scoazec A. et al. Expression of interleukin - 18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104: 1598-1603.
- Blankenberg S., Tiret L., Bickel C. et al. Interleukin - 18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30.
- Yamashita H., Shimada K., Seki E. et al. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina. Am. J. Cardiol. 2003; 91: 133-136.
- Blankenberg S., Luc G., Ducimetiere P. et al. Interleukin - 18 and the risk for coronary heart disease in European men. The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003; 108: 2453-2459.
- Mallat Z., Henry P., Fressonnet R. et al. Increased plasma concentrations of interleukin - 18 in acute coronary syndromes. Heart 2002; 88: 467-469.
- Насонова В. А., Бунчук H. В. (ред.). Избранные лекции по клинической ревматологии: Учеб. пособие для слушателей институтов и факультетов последипломного образования. М.: Медицина; 2001.
- Wong С. К., Li Е. К., Lam С. W. К. Elevation of plasma interleukin - 18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology 2000; 39: 1078-1081.
- Park M. C., Park Y. В., Lee S. K. Elevated interleukin - 18 levels correlated with disease activity in systemic lupus erythematosus. Clin. Rheumatol. 2004; 23: 225-229.
- Robak E., Robak Т., Wozniacka A. et al. Pro-inflammatory interferon-gamma-inducing monokines (interleukin-12, interleukin-18, interleukin-15) - serum profile in patients with systemic lupus erythematosus. Eur. Cytokine Netw. 2002; 13: 364-368.
- Amerio P., Frezzolini A., Abeni D. et al. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with proinflammatory cytokines. Clin. Exp. Rheumatol. 2002; 20: 535-538.
- Calvani N., Richards H. В., Tucci M. et al. Up-regulation of IL-18 and predominance of a Th-1 immune response is a hallmark of lupus nephritis. Clin. Exp. Immunol. 2004; 138: 171-178.
- Wong С. К., Ho С. Y., Li E. K. et al. Elevated production of interleukin - 18 is associated with renal disease in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 2002; 130: 345-351.
- Tso Т. K., Huang W. N., Huang H. Y., Chang С. К. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. Rheumatology 2006; 45: 1148-1153.
- Hochberg M. С. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr. and Rheum. 1997; 40: 1725-1734.
- Wilson W. A., Gharavi A. E., Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthr. and Rheum. 1999; 42: 1309-1311.
- Bombardier C., Gladman D. D., Urowitz M. B. et al. Derivation of the SLEDAI (a disease activity index for lupus patients). Arthr. and Rheum. 1992; 35: 630-640.
- Gladman D. D., Ginzler E., Goldsmith С. H. et al. The development and initial validation of the Systemic Lupus Erythematosus Collaborating Clinics / American College of Reumatology damage index for systemic lupus erythematosus. Arthr. and Rheum. 1996; 39: 363-369.
- Kannel W. В., Castelli W. P., McNamara M. P. The coronary profile: 12-year follow-up in Framingham Study. J. Occup. Med. 1987; 9: 611-619.
- Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation 2002; 106: 3143.
- World Health Organization. International Society of Hypertension Guidelines for management of hypertension. Guidelines Subcommittee. J. Hypertens. 1999; 17: 151-183.
- Перова Н. В., Косматова О. В. Простой метод оценки снижения суммарного коронарного риска при лечении гипертонии и гиперлипидемии. Кардиология 2002; 3: 23-25.
- Haward G., Sharrett A. R., Heiss G. et al. Carotid artery intima-media thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993; 24: 1297-1304.
- Александрова E. H., Насонов E. Л., Ковалев В. Ю. Количественный иммуноферментный метод определения антител к кардиолипину в сыворотке крови. Клин. ревматол. 1995; 4: 35-39.
- Segal R., Bermas В. L., Dayan М. et al. Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1 / T helper cell 2 type cytokines in disease. J. Immunol. 1997; 158: 3009-3016.
- Viallard J. F., Pellegrin J. L., Ranchin V. et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 1999; 115: 189-195.
- Aso Y., Okumura K., Takebayashi K. et al. Relationships of plasma interleukin - 18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabet. Care 2003; 26: 2622-2627.
- Hung J., McQuillan В. M., Chapman С. M. L. et al. Elevated interleukin - 18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 1268-1273.
- McLachlan С. S., Chua W. C., Wong P. T. et al. Homocysteine is positively associated with cytokine IL-18 plasma levels in coronary artery bypass surgery patients. Biofactors 2005; 23: 69-73.
![](/img/style/loading.gif)